Eyewire News: The Podcast
11.12.25
Sydnexis receives another regulatory approval for its childhood myopia eye drop; Eli Lilly makes two major investments in ophthalmology; and Nanoscope reports new long-term data for its intravitreal optogenetic therapy for RP. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
12.31.25
2025 Year in Review - Part 212.24.25
2025 Year in Review - Part 112.17.25
Update on Reproxalap PDUFA Timing11.18.25
Live Coverage of B+L Investor DayShow More